Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

ICICI Prudential Life Insurance - Business momentum upwards; valuations remain attractive - ICICI Securities

Posted On: 2021-04-20 11:05:42 (Time Zone: UTC)

The big strategic achievement from FY21 for ICICI Prudential Life Insurance (IPRU) is the establishment of an ex-ICICI Bank product as well as distribution capability. Key effects of this strategy include: (1) Growth in non-linked savings portfolio by healthy 56% YoY in FY21, (2) introduction of guaranteed savings as well as deferred annuity products and (3) spurt in new distribution channels with ~600 partnerships including 23 banks and > 185,000 advisors. As such, despite ICICI Bank's contribution declining to 31% of the overall APE which in turn declined 13% YoY, total FY21 VNB was flat at Rs16bn. Management aims to increase annual VNB by Rs10bn over FY22-23 (implied CAGR of 27%). Considering the turnaround in business momentum and attractive valuations (1.8x based on FY23E EV of Rs366bn), we upgrade the stock from Add to BUY.

- Becoming more diversified than peers? The question is absolutely pertinent for IPRU considering its current mix of distribution and products and VNB contribution. The company appears better prepared for more bottom-up approach to follow a demand-based business strategy as it offers the entire bouquet of retail protection, group term, credit life, annuities, linked as well as traditional segments. The distribution mix (APE terms) of FY21 stood at banca (ICICI Bank): 31%, banca (others): 11%, agency:24%, direct: 13%, partnership distribution: 9% and group: 12% while product mix of APE stood at linked: 48%; non-linked: 31%, protection: 16%, group: 5%. VNB contribution in FY21 stood at protection: 53.4%, non-linked savings: 24.2% and linked savings at 22.3%.

- Protection pricing to remain unchanged as volume becomes a more important VNB driver in FY22/23. IPRU aims to reach Rs26.5bn VNB in FY23 which would imply an APE of Rs106bn in FY23 at 25% VNB margin. This would necessitate APE CAGR of 31% for IPRU Life between FY21-23E. Maintaining pricing (as indicated by IPRU in protection) can be beneficial to attain volume growth which should also benefit from better traction of new products and distribution channels harnessed in FY21. Total claims on account of Covid for FY21 were Rs4.59bn, while claims net of reinsurance were Rs2.64bn. Additional provision remains at Rs3.32bn towards Covid, not utilised so far but accounted in the EV walk.

- Operating performance has been incrementally positive with (1) positive persistency variation (Rs1.1bn) in FY21 which has also been driven by higher non-par mix which has 13th month persistency of 94%, (2) lower cost ratios (100/80 bps YoY for total /savings business) in FY21 and (3) recovery in APE growth (27% growth in Q4FY21) with health trends witnessed till date in Q1FY22.

- Trading less than 2x FY23E P/EV irrespective of whether VNB falls short of the FY23E target of Rs26.5bn, upgrade from Add to BUY. Based on, 15% APE growth and flattish VNB margins, EV estimate for FY23 turns out to be Rs365.7bn after factoring a negative economic variance possible with increase in interest rates. Meeting the FY23 VNB target is a positive optionality.

Shares of ICICI Prudential Life Insurance Company Ltd was last trading in BSE at Rs.478.3 as compared to the previous close of Rs. 452.25. The total number of shares traded during the day was 1507681 in over 39997 trades.

The stock hit an intraday high of Rs. 503.95 and intraday low of 462.35. The net turnover during the day was Rs. 740651842.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Cadila Healthcare - Divests animal health business - ICICI Securities

Q4FY21 Result Update - Granules India - ICICI Direct

Q4FY21 Company Update - Firstsource Solutions - ICICI Direct

Q4FY21 Company Update - Sonata Software - ICICI Direct

Company Update - Cadila Healthcare - ICICI Direct

Q4FY21 Result Update - Kalpataru Power - ICICI Direct

Q4FY21 Result Update - KEC International - ICICI Direct

Q4FY21 Company Update - Ltd - ICICI Direct

Maintain REDUCE on Asian Paints - Exceeds expectations - HDFC Securities

JMC Projects Results Report - Poised for growth - HDFC Securities

Maintain ADD on Godrej Consumers - Miss in 4Q margin; inspiring addition to team - HDFC Securities

Maintain BUY on Birla Corporation - Healthy performance - HDFC Securities

Subscriber watch - Bharti wins more market share across categories - ICICI Securities

Siemens Ltd - Healthy margins with growth recovery - ICICI Securities

Godrej Consumer Products - Jigsaw falling in place; retain top pick status - ICICI Securities

Thyrocare Technologies - Margins subdued despite growth recovery - ICICI Securities

Q4FY21 Result Update - Zydus Wellness - ICICI Direct

Q4FY21 Result Update - EIH Ltd - ICICI Direct

Q4FY21 Company Update - Intellect Design Arena - ICICI Direct

Q2FY21 Company Update - Siemens Ltd - ICICI Direct

UltraTech Cement - In-line strong performance; Capex plan retained - HDFC Securities

April AMFI Data - Mr. Aashish P Somaiyaa, Chief Executive Officer - White Oak Capital

Maintain ADD on Navin Fluorine International - High-value business aids growth - HDFC Securities

Maintain BUY on Kansai Nerolac - Raw material cost pressure palpable - HDFC Securities

Cholamandalam Investment and Finance Company - A steady quarter - HDFC Securities

Grindwell Norton - Moving towards a new orbit - ICICI Securities

Kansai Nerolac Paints - Another (margin) miss story; not unexpected though - ICICI Securities

UltraTech Cement - 2nd covid wave a blip; long-term thesis intact - ICICI Securities

Zydus Wellness - Symphony; retain top pick status - ICICI Securities

Cholamandalam Investment and Finance - Beefing-up buffer to cushion earnings; positioned to grow when normalcy returns - ICICI Securities

Navin Fluorine International - Demanding valuation caps upside - ICICI Securities

Q4FY21 Result Update - Dabur India - ICICI Direct

Q4FY21 Result Update - Tata Consumer Products - ICICI Direct

Q4FY21 Result Update - DCB Bank - ICICI Direct

Q4FY21 Result Update - Navin Fluorine - ICICI Direct

Q4FY21 Result Update - UltraTech Cement - ICICI Direct

Q4FY21 Result Update - Kansai Nerolac Paints - ICICI Direct

Q4FY21 Result Update - IDFC First Bank - ICICI Direct

Q4FY21 Result Update - Grindwell Norton - ICICI Direct

Cholamandalam Invest. & Finance - Q4FY21 Result Update - YES Securities

Ultratech Cement Ltd - Q4FY21 Result Update - YES Securities

JMC Projects (India) - Q4 FY21 first cut - Robust Performance - YES Securities

Brokerage Views on DCB Bank's Q4FY21 results

Maintain ADD on Dabur - Exciting FY21; miss in 4Q margin - HDFC Securities

Deepak Nitrite Results Review - Decent performance - HDFC Securities

Maintain ADD on DCB Bank - Lower provisions drive beat in earnings - HDFC Securities

Bandhan Bank Report - Surging micro-credit stress - HDFC Securities

Avenue Supermarts Q4FY21 Results Review - In-line performance; FY22 recovery tapered down - HDFC Securities

Chola Inv. & Fin. - Q4 FY21 first take - 'Strong on growth, in-line on asset quality'

Blue star Ltd - Q4FY21 Result Update - YES Securities

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020